(NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, today announced that George Paletta, Jr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback